CT evaluation of fibrosing alveolitis - Applications and insights

Journal of Thoracic Imaging

Volumn 11, Issue 4, 1996, Pages 231-249

  Hansell, David M ^a,b   Wells, Athol U ^c  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Computed tomography (CT), thin section; Lung, fibrosis; Lung, function; Pneumonitis, desquamative interstitial; Pneumonitis, usual interstitial

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; FIBROSING ALVEOLITIS; HUMAN; INTERMETHOD COMPARISON; LUNG BIOPSY; PATHOGENESIS; REVIEW;

EID: 0029963715     PISSN: 08835993     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005382-199623000-00001     Document Type: Review

References (129)

1. Corrin B. Pathology of interstitial lung disease. In: Harasawa M, Fukuchi Y, Morinari H, eds. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press. 1989:149-168.
2. Scadding JG. Chronic diffuse interstitial fibrosis of the lungs. Br Med J 1960;1:443-50.
3. Hogg JC. Chronic interstitial lung disease of unknown cause: a new classification based on pathogenesis. AJR 1991;156:225-33.
4. Turner-Warwick M. Cryptogenic fibrosing alveolitis. In: Freundilch IM, Bragg DG, eds. A radiologic approach to diseases of the chest. Baltimore: Williams and Wilkins, 1992:445-54.
5. Harrison NK, Myers R, Corrin B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144:706-13.
6. Hamman L, Rich AR. Acute diffuse interstitial fibrosis of the lungs. Bull Johns Hopkins Hosp 1994;74:177-212.
7. Scadding JG, Hinson KF. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): correlation of histology at biopsy with prognosis. Thorax 1967;22:291-304.
8. Askin FB. Acute interstitial pneumonia: histopathologic patterns of acute lung injury and the Hamman-Rich syndrome revisited. Radiology 1993;188:620-1.
9. Katzenstein ALA, Myers JL, Mazur MT. Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986;10:256-67.
10. Primack SL, Hartman TE, Ikezoe J, Akira M, Sakatani M, Müller NL. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993;188:817-20.
11. Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-9.
12. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: Clinical features and their influence on survival. Thorax 1980;35:171-80.
13. Liebow AA. Definition and classification of interstitial pneumonias in human pathology. Prog Respir Res 1975;8:1-33.
14. Mino M, Noma S, Kobashi Y, Iwata T. Serial changes of cystic air spaces in fibrosing alveolitis: a CT-pathological study. Clin Radiol 1995;50:357-63.
15. Fromm GB, Dunn LJ, Harris JO. Desquamative interstitial pneumonitis: characterization of free intraalveolar cells. Chest 1980;77:552-4.
16. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonitis. Am J Med 1965;39:369-404.
17. Katzenstein AL, Askin FB. Idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis. In: Bennington JL, ed. Surgical pathology of non-neoplastic lung disease. 2nd ed. Philadelphia: WB Saunders, 1990:58-96.
18. Katzenstein ALA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
19. Thurlbeck WM, Miller RR, Müller NL, Rosenow EC. Chronic infiltrative lung disease. In: Diffuse diseases of the lung: a team approach. Philadelphia: BC Decker, 1991:101-38.
20. Corrin B. Diseases characterised by restrictive ventilatory impairment. In: Symmers WS, ed. Systemic pathology: the lungs, 3rd ed. Edinburgh: Churchill Livingstone, 1990:197-234.
21. Panos RJ, Moretensen RL, Niccoli SA, King TE. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990;88:396-404.
22. Patchefsky AS, Israel HL, Hoch WS, Gordon G. Desquamative interstitial pneumonia: relationship to interstitial fibrosis. Thorax 1973;28:680-93.
23. Tubbs RR, Benjamin SP, Reich NE, McCormack LJ, van Ordstrand HS. Desquamative interstitial pneumonitis: cellular phase of fibrosing alveolitis. Chest 1977;72:159-65.
24. Johnston I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. Br Med J 1990;301:1017-21.
25. Johnston IDA, Rudd RM. BTS study of cryptogenic fibrosing alveolitis (CFA): clinical features at presentation. Thorax 1994;49:394-5P.
26. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case control study of environmental exposure to dust. Br Med J 1990;301:1015-7.
27. Kaelin RM, Kapanci Y, Tcshopp JM. Diffuse interstitial lung disease associated with hydrogen peroxide inhalation in a dairy worker. Am Rev Respir Dis 1988;137:1233-5.
28. Ramage JE, Roggli VL, Bell DY, Piantodosi CA. Interstitial lung disease and domestic wood burning. Am Rev Respir Dis 1988;137:1229-32.
29. Al-Jarad N, Strickland B, Pearson MC, Rubens MB, Rudd RM. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study. Thorax 1992;47:645-50.
30. Wells AU, Du Bois RM. Prediction of disease progression in idiopathic pulmonary fibrosis. Eur Respir J 1994;7:637-9.
31. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, Woodcock AA. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995;50: 1234-9.
32. Briggs DC, Vaughn RW, Welsh KJ, et al. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 1991;338:661-2.
33. Wells AU, Cullinan P, Hansell DM, et al. Fibrosing alveolitis associated with systemic sclerosis as a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1994;149:1583-90.
34. Schwartz DA, Helmers RA, Galvin JR, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1994;149:450-4.
35. Tukiainen P, Taskinen E, Holsti P, Korhola O, Valle M. Prognosis of cryptogenic fibrosing alveolitis. Thorax 1983;38:349-55.
36. Agusti C, Xaubet A, Roca J, Agusti AG, Rodriguez-Roisin R. Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax 1992;47:1035-40.
37. Wright PH, Heard BE, Steel SJ, Turner-Warwick M. Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic and physiological features. Br J Dis Chest 1981;75:61-70.
38. Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax 1989;44:280-8.
39. Raghu G, Depaso WJ, Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis 1991;144:291-6.
40. Douglas WW, Ryu JH, Bjoraker JA, et al. Colchicine therapy for idiopathic fibrosis. Am J Respir Crit Care Med 1996;153:A149.
41. Johnston IA, Gomm SA, Kalra S, Woodcock AA, Evans CC, Hind CRK. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom. Eur Respir J 1993;6:891-3.
42. Stack BHR, Grant IWB, Irvine WJ, et al. Idiopathic diffuse interstitial lung disease. Am Rev Respir Dis 1965;92:939-48.
43. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978;298:935-9.
44. Gaensler EA, Carrington CB. Open lung biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic and physiological correlations in 502 patients. Ann Thorac Surg 1980;30:411-26.
45. Line BR, Fulmer JD, Reynolds HY, et al. Gallium-67 citrate scanning in the staging of idiopathic pulmonary fibrosis: correlation with physiologic and morphological features and bronchoalveolar lavage. Am Rev Respir Dis 1978;118:355-65.
46. Baron M, Feiglin D, Hyland R, Urowitz MB, Shiff B. 67-Gallium lung scans in progressive systemic sclerosis. Arthritis Rheum 1983;26:969-74.
47. 99mTc-DTPA clearance. Respir Med 1989;83:1-12.
48. Diot P, Diot E, Lemarie E, et al. Imaging of pulmonary disease in scleroderma with J001X scintigraphy. Thorax 1994;49:504-8.
49. Weaver AL, Divertie MB, Titus JL. Pulmonary scleroderma. Dis Chest 1968;54:490-8.
50. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). Am J Med 1969;46:428-40.
51. Taormina VJ, Miller WT, Gefter WB, Epstein DM. Progressive systemic sclerosis subgroups: Variable pulmonary features. AJR 1981;137:277-85.
52. Arroliga AC, Podell DN, Matthay RA. Pulmonary manifestations of scleroderma. J Thorac Imaging 1992;7:30-45.
53. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131:770-7.
54. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features a prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33.
55. Haddock JAA, Hansell DM. The terminology and radiology of cryptogenic organising pneumonia. Br J Radiol 1992;65:674-80.
56. Wells AU, Du Bois RM. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993;14:655-66.
57. Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: High resolution CT versus radiography. Radiology 1990;176:755-9.
58. Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol 1991;18:1520-8.
59. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology 1989;171:111-6.
60. Grenier P, Valeyre D, Cluzel P, Brauner MW, Lenoir S, Chastang C. Chronic diffuse interstitial lung disease: diagnostic value of chest radiography and high-resolution CT. Radiology 1991;179:123-32.
61. Padley SPG, Hanseel DM, Flower CDR, Jennings P. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol 1991;44:227-31.
62. Nishimura K, Izumi T, Kitaichi M, Nagai S, Itoh H. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung diseases. Chest 1993;104:1149-55.
63. Grenier P, Chevret S, Beigelman C, Brauner MW, Chastang C, Valeyre D. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis. Radiology 1994;191:383-90.
64. Tung KT, Wells AU, Rubens MB, Kirk JM, Du Bois RM, Hansell DM. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax 1993;48:334-8.
65. Primack SL, Hartman TE, Hansell DM, Mul̈ler NL. End-stage lung: CT findings in 61 patients. Radiology 1993;189:681-6.
66. Lee KS, Kullnig P, Hartman TE, Müller NL. Cryptogenic organizing pneumonia: CT findings in 43 patients. AJR 1994;162:543-6.
67. Müller NL, Miller RR, Webb WR, Evans KG, Ostrow DN. Fibrosing alveolitis: CT pathologic correlation. Radiology 1986;160:585-8.
68. Strickland B, Strickland NH. The value of high definition, narrow section computed tomography in fibrosing alveolitis. Clin Radiol 1988;39:589-94.
69. Bergin C, Castellino RA. Mediastinal lymph node enlargement on CT scans in patients with usual interstitial pneumonitis. AJR 1990;154:251-4.
70. Bhalla M, Silver RM, Sheppard JA, McLoud TC. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR 1993;161:269-72.
71. Sampson C, Hansell DM. The prevalence of enlarged mediastinal lymph nodes in asbestos-exposed individuals: a CT study. Clin Radiol 1992;45:340-2.
72. Martinez FJ, Karlinsky JB, Gale ME, Jung-Legg Y, Benditt JO. Intrathoracic lymphadenopathy: A rare manifestation of rheumatoid pulmonary disease. Chest 1990;97:1010-2.
73. Garber SJ, Wells AU, Du Bois RM, Hansell DM. Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis. Br J Radiol 1992;66:983-6.
74. Venn GE, Kay PH, Midwood CJ, Goldstraw P. Open lung biopsy in patients with diffuse pulmonary shadowing. Thorax 1985;40:931-5.
75. Cherniack RM, Colby TV, Flint A, et al. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991;144:892-900.
76. Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189:693-8.
77. Dill J, Chose T, Landrigan P, Mackeen AD, MacNeill AR. Cryptogenic fibrosing alveolitis. Chest 1975;67:411-6.
78. Moss ML. The chest x-ray in idiopathic pulmonary fibrosis. In: Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects (moderator: Crystal RG). Ann Intern Med 1976;85:769-88.
79. Winterbauer RH, Hammar SP, Hallman KO, et al. Diffuse interstitial pneumonitis: clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am J Med 1978;65:661-72.
80. Fulmer DG, Roberts WC, von Gal ER, Crystal RG. Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest 1979;63:665-76.
81. Chinet T, Jaubert F, Dusser D, Danel C, Chretien J, Huchon G. Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax 1990;45:675-8.
82. 99mTcDTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J 1993;6:797-802.
83. Labrune S, Chinet T, Collignon MA, Barritault L, Huchon GJ. Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis. Eur Respir J 1994;7:651-6.
84. Watters LC, Schwartz MI, Cherniack RM, et al. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy. Am Rev Respir Dis 1987;135:696-704.
85. Turner-Warwick M, Haslani PL. The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis. Am Rev Respir Dis 1987;135:26-34.
86. Haslam PL, Turton CWG, Lukoszek A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980;35:328-9.
87. Howard P. Clinical usefulness of bronchoalveolar lavage. Eur Respir J 1990;3:377-8.
88. Watters LC, King TE, Cherniack RM, et al. Bronchoalveolar lavage fluid neutrophils increase after corticosteroid therapy in smokers with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986;133:104-9.
89. Hruban RH, Meziane MA, Zerhouni EA, et al. High resolution computed tomography of inflation-fixed lungs. Am Rev Respir Dis 1987;136:935-40.
90. Webb WR, Stein MG, Finkbeiner WE, Im JG, Lynch D, Gamsu G. Normal and diseased isolated lungs: High-resolution CT. Radiology 1988;166:81-7.
91. Itoh H, Murata K, Konishi J, Nishimura K, Kitaichi M, Izumi T. Diffuse lung disease: pathologic basis for the high-resolution computed tomography findings. J Thorac Imag 1993;8:176-88.
92. Webb WR, Müller NL, Naidich DP. Standardized terms for high resolution lung CT: a proposed glossary. J Thorac Imag 1993;8:167-75.
93. Leung AN, Miller RR, Müller NL. Parenchymal opacification in chronic infiltrative lung diseases: CT-pathologic correlation. Radiology 1993;188:209-14.
94. Remy-Jardin M, Remy J, Giraud F, Wattine L, Gosselin B. Computed tomography (CT) assessment of ground-glass opacity: semiology and significance. J Thorac Imaging 1993;8:249-64.
95. Müller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987;165:731-4.
96. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986;133:97-103.
97. Wells AU, Hansell DM, Corrin B, et al. High resolution computed tomography assessment of disease activity in the fibrosing alveolitis of systemic sclerosis: a histopathological correlation. Thorax 1992;47:738-42.
98. Collins CD, Wells AU, Hansell DM, et al. Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol 1994;49:236-40.
99. Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 1992;182:337-42.
100. Wells AU, Hansell DM, Rubens MB, Cullinan P, Black CM, Du Bois RM. The predictive value of thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis 1993;148:1076-82.
101. Wells AU, Rubens MB, Du Bois RM, Hansell DM. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. AJR 1993;161:1159-65.
102. Akira M, Yamamoto S, Yokoyama K, et al. Asbestosis: High-resolution CT-pathologic correlation. Radiology 1990;176:389-94.
103. Terriff BA, Kwan SY, Chan-Yeung MM, Müller NL. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients. Radiology 1992;184:445-9.
104. Hartman TE, Primack SL, Kang EY, et al. Disease progression in UIP compared with DIP: assessment with HRCT. Chest, in press.
105. Hartman TE, Primack SL, Swensen SJ, Hansell D, McGuinness G. Müller NL. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993;187:787-90.
106. Barrowcliffe MP, Jones LG. Solute permeability of the alveolar capillary barrier. Thorax 1987;42:1-10.
107. 99mTc-DTPA. Am Rev Respir Dis 1990;141:445-9.
108. 99mTc-DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis. Thorax 1990;45:525-9.
109. Wells AU, Hansell DM, Rubens MB, Black CM, Du Bois RM. The clinical utility of thin section computed tomography in the detection of changes in disease severity in fibrosing alveolitis. Am Rev Respir Dis 1993;147:A593.
110. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: Response to corticosteroid treatment and its effect on survival. Thorax 1980;35:593-9.
111. Gaensler EA, Carrington CB, Coutu RE, Fitzgerald MX. Radiographic-physiologic-pathologic correlations in interstitial pneumonias. Prog Respir Res 1975;8:223-41.
112. Wells AU, King AD, Rubens MB, Du Bois RM, Hansell DM. Thin section computed tomography and pulmonary function tests in lone cryptogenic fibrosing alveolitis: a morphological-functional correlation. Am J Respir Crit Care Med 1994;149:A281.
113. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994;150:462-8.
114. Peterson MW, Monick M, Hunninghake GW. Prognostic role of eosinophils in pulmonary fibrosis. Chest 1987;92:51-6.
115. Janoff A, White R, Carp H, Harel S, Dearing R, Lee D. Lung injury induced by leucocyte proteases. Am J Pathol 1979;97:111-29.
116. Weissman G, Smolen JE, Korchak HM. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 1980;303:27-34.
117. Wallaert B, Hatron PY, Grosbois JM, Tonnel AB, Devulder B, Voison C. Subclinical pulmonary involvement in collagen vascular diseases assessed by bronchoalveolar lavage. Am Rev Respir Dis 1986;33:574-80.
118. Haslam PL. Bronchoalveolar lavage. Seinin Respir Med 1984;6:55-70.
119. Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage (BAL) cellularity and its relationship to disease extent in fibrosing alveolitis: a comparison between the fibrosing alveolitis of systemic sclerosis (FASSc) and lone cryptogenic fibrosing alveolitis. Am J Respir Crit Cure Med 1986;153:A271.
120. Miller KS, Smith EA, Kinsella M, Schabel SI, Silver RM, Lung disease associated with progressive systemic sclerosis: assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity. Am Rev Respir Dis 1990;141:301-6.
121. Garcia JGN, Wolven RG, Garcia PL, Keogh BA. Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases. Am Rev Respir Dis 1986;133:444-9.
122. Costabel U, Teschler H, Guzman J. et al. Uniformity of BAL lymphocyte subpopulations between different sites in interstitial lung disease. Eur Respir J 1989;2(suppl):624s.
123. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med 1990;84:365-9.
124. Young RH, Mark GJ. Pulmonary vascular changes in scleroderma. Am J Med 1978;84:998-1004.
125. Murray ME, Chan T, Wells AU, Du Bois RM, Hansell DM. Differences in the morphological appearances of cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis on HRCT. Clin Radiol 1994;49:A747.
126. Gamsu G. Radiographic manifestations of thoracic involvement by collagen vascular diseases. J Thorac Imaging 1992;7:1-12.
127. Johkoh T, Ikezoe J, Kohno N, et al. High-resolution CT and pulmonary function tests in collagen vascular disease: comparison with idiopathic pulmonary fibrosis. Eur J Radiol 1994;18:113-21.
128. Wells AU, King AD, Rubens MB, Black CM, Hansell DM, Du Bois RM. Functional impairment in fibrosing alveolitis after matching for CT findings, demographic factors and smoking: a comparison between cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1994;149:A281.
129. Du Bois RM. Diffuse lung disease: an approach to management. Br Med J 1994;309:175-9.